Amanda Wagner

Chief Executive Officer at Immunitas Therapeutics - Waltham, MA, US

Amanda Wagner's Contact Details
HQ
N/A
Location
Cambridge,Massachusetts,United States
Company
Immunitas Therapeutics
Amanda Wagner's Company Details
Immunitas Therapeutics logo, Immunitas Therapeutics contact details

Immunitas Therapeutics

Waltham, MA, US • 50 - 99 Employees
BioTech/Drugs

Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas' programs are derived from a cross-functional, highly integrated, single cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering. IMT-009, a first-in-class T & NK cell modulator targeting CD161, is being developed for the treatment of solid tumors and hematological malignancies. The company was founded with leading scientists from Dana Farber, MGH, the Broad, and MIT. In 2019, Immunitas raised a $39M Series A from a strong syndicate of investors including the Longwood Fund, Hillhouse, NVF, Leaps by Bayer, and M Ventures.

N/A
Details about Immunitas Therapeutics
Frequently Asked Questions about Amanda Wagner
Amanda Wagner currently works for Immunitas Therapeutics.
Amanda Wagner's role at Immunitas Therapeutics is Chief Executive Officer.
Amanda Wagner's email address is ***@immunitastx.com. To view Amanda Wagner's full email address, please signup to ConnectPlex.
Amanda Wagner works in the Research industry.
Amanda Wagner's colleagues at Immunitas Therapeutics are Caitlin Goshert, Char Gross, Cynthia Hession, Victoria Gitten, Joan Resnicow, Teresse Rham, Lynette Herscha and others.
Amanda Wagner's phone number is N/A
See more information about Amanda Wagner